Double Helix Biotechnology Dev. has been acquired by Interpublic Group of Companies
Double Helix Bio-Technology Development Ltd. (Double Helix), a leading, global provider of market research and market access services to the pharmaceutical and medical device industries, has been sold to McCann Health, owned by The Interpublic Group of Companies Inc. Financial details of this transaction have not been disclosed.
Founded by Dr Wayne Phillips and based in London, Double Helix not only specializes in the established markets of the US and Europe, but also focuses on emerging markets, providing clients with a truly global perspective. In the past year, Double Helix has performed projects across more than 40 countries for over 30 major pharmaceutical multinational clients. Dr Phillips will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
McCann Health is a part of McCann Worldgroup, the largest marketing communications agency network in the world, and is a leading healthcare agency network owned by The Interpublic Group of Companies Inc.
Oaklins Cavendish, based in the UK, acted as financial advisor to the seller.


Talk to the deal team


Related deals
Technology & Strategy Group expands with the integration of TOPIC
Technology & Strategy Group (T&S), a European expert in consulting, digital and engineering, is developing its engineering business with the arrival of new Dutch partner TOPIC, an expert in embedded systems. The integration of TOPIC will further strengthen T&S’ expertise in system, hardware and software development, which will enable the delivery of more complex, turnkey projects and complete solutions, including end-to-end product development.
Learn moreEQUA Simulation has been acquired by Glodon Company Limited
The private shareholders of EQUA Simulation AB have sold the company to Glodon Company Limited through its Finnish subsidiary MagiCAD.
Learn moreNavita has been sold to Enghouse Systems
Oria Capital has sold its portfolio company Navita to Enghouse Systems Limited.
Learn more